Data Name | Published Year | Array Platform | Sample Size |
GEO Accession ID | Lapointe | 2004 | cDNA |
112 | GSE3933 | Yu | 2004 |
HG-U95Av2 | 108 | GSE6919 | Varambally |
2005 | HG-U133 Plus 2 | 19 | GSE3325 |
Tomlins | 2007 | cDNA | 76 |
GSE6099 | Data Name | Published Year | Array Platform |
prostate
Yu, Y. P., Landsittel, D., Jing, L., Nelson, J., Ren, B., Liu, L., McDonald, C., Thomas, R., Dhir, R., Finkelstein, S. et al. (2004). Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. Journal of Clinical Oncology 22 2790.
Varambally, S., Yu, J., Laxman, B., Rhodes, D. R., Mehra, R., Tomlins, S. A., Shah, R. B., Chandran, U., Monzon, F. A., Becich, M. J. et al. (2005). Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer cell 8 393-406.
Tomlins, S. A., Mehra, R., Rhodes, D. R., Cao, X., Wang, L., Dhanasekaran, S. M., Kalyana-Sundaram, S., Wei, J. T., Rubin, M. A., Pienta, K. J. et al. (2006). Integrative molecular concept modeling of prostate cancer progression. Nature genetics 39 41-51.